These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11820582)

  • 1. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
    Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
    Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim E; Goussia A; Agnantis NJ
    Virchows Arch; 1999 Jan; 434(1):45-50. PubMed ID: 10071234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
    Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
    Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
    Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
    Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of Cath-D and CD44 in laryngeal squamous cell carcinomas].
    Wu H; Wang W; Xu L
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 May; 12(5):195-7. PubMed ID: 11189153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunohistochemical expression of cathepsin D in colorectal cancer.
    Valentini AM; Pirrelli M; Armentano R; Caruso ML
    Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
    Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
    Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Goto A; Sakamoto A; Atomi Y
    J Gastroenterol; 2003; 38(1):37-44. PubMed ID: 12560920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic evaluation of metallothionein expression in human colorectal neoplasms.
    Ioachim EE; Goussia AC; Agnantis NJ; Machera M; Tsianos EV; Kappas AM
    J Clin Pathol; 1999 Dec; 52(12):876-9. PubMed ID: 10711249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
    Bedner E; Harezga B; Osborn M; Domagała W
    Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of cathepsin D in laryngeal epithelial lesions: correlation with CD44 expression, p53 and Rb status and proliferation associated indices.
    Goussia A; Ioachim E; Peschos D; Assimakopoulos D; Vougiouklakis T; Skevas A; Agnantis N
    Anticancer Res; 1999; 19(4B):3055-60. PubMed ID: 10652592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
    Formentini A; Henne-Bruns D; Kornmann M
    Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.